Company Filing History:
Years Active: 2021-2023
Title: Michael Salmon: Innovator in Microfluidic Systems
Introduction
Michael Salmon is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of microfluidic systems, particularly in modeling diseases of the lung and gastrointestinal system. With a total of 3 patents, his work is paving the way for innovative solutions in medical research and treatment.
Latest Patents
One of Michael Salmon's latest patents is focused on advanced pulmonary models. This invention relates to microfluidic systems and methods for in vitro modeling diseases of the lung and small airway. It includes a system for testing responses of a microfluidic Small Airway-on-Chip infected with infectious agents, such as respiratory viruses. This model allows for the testing of anti-inflammatory and anti-viral compounds, as well as monitoring immune cell activity. Another significant patent involves an in vitro gastrointestinal model comprising lamina propria-derived cells. This microfluidic gut-on-chip mimics the structure and function of specific areas of the gastrointestinal system. It enables the modeling of inflammatory gastrointestinal tissue, such as Crohn's disease and colitis, and facilitates drug testing for reducing inflammation.
Career Highlights
Michael Salmon is currently employed at Emulate, Inc., where he continues to develop innovative microfluidic technologies. His work is instrumental in advancing the understanding of respiratory and gastrointestinal diseases through in vitro models.
Collaborations
Michael collaborates with notable colleagues, including S Jordan Kerns and Jenifer Obrigewitch, who contribute to the research and development of microfluidic systems.
Conclusion
Michael Salmon's innovative work in microfluidic systems is making a significant impact in the fields of respiratory and gastrointestinal research. His patents reflect a commitment to advancing medical science and improving treatment options for patients.